Veera Ojala
vekaoj@utu.fi +358 29 450 3786 +358 50 354 1288 Tykistökatu 6 Turku ORCID identifier: https://orcid.org/0000-0001-5204-8899 |
Publications
- De Novo Multi-Omics Pathway Analysis Designed for Prior Data Independent Inference of Cell Signaling Pathways (2024)
- Molecular and Cellular Proteomics
(A1 Refereed original research article in a scientific journal) - ERBB4 as a potential therapeutic target in cancer (2024) Ojala, Veera
(G5 Article dissertation ) - Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth in vivo (2024)
- ChemBioChem
(A1 Refereed original research article in a scientific journal) - An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations (2022)
- Cancer Research Communications
(A1 Refereed original research article in a scientific journal) - Therapeutic Potential of Targeting the SUMO Pathway in Cancer (2021)
- Cancers
(A2 Refereed review article in a scientific journal ) - The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration (2020)
- Journal of Biological Chemistry
(A1 Refereed original research article in a scientific journal) - An unbiased in vitro screen for activating epidermal growth factor receptor mutations (2019)
- Journal of Biological Chemistry
(A1 Refereed original research article in a scientific journal) - Genome-wide screen of gamma-secretase-mediated intramembrane cleavage of receptor tyrosine kinases (2017)
- Molecular Biology of the Cell
(A1 Refereed original research article in a scientific journal)